Latest Advances in Lung Cancer Research

Non-smoking Asian American and Pacific Islander women face higher lung cancer risks, prompting research into genetic and environmental causes and new treatments.

“Ground-glass opacity” on lung CT scans, a hazy sign of potential cancer, is linked to higher survival rates, emphasizing the importance of early detection.

New NCCN guidelines help doctors treat lung cancer more effectively with early detection, personalized treatment plans, and comprehensive supportive care recommendations.

AstraZeneca’s Imfinzi shows promise in treating aggressive small cell lung cancer, potentially offering a new, more effective treatment option for this hard-to-treat disease.

The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki, a new drug for treating HER2-positive unresectable or metastatic breast cancer in adults.

Cancer death rates in the U.S. have dropped 33% since 1991, saving 3.8 million lives, but disparities and challenges in certain cancers remain.

Lung cancer rates are increasing among Asian American women, according to a new study published in the journal Cancer.

Weill Cornell Medicine scientists create a mouse model to study lung cancer’s transformation into deadly SCLC.

David P. Carbone, MD, PhD, sought to transform lung cancer care and did it—but didn’t anticipate the personal journey it would put him on.

Rising lung cancer in young, non-smoking women puzzles doctors; research on potential pregnancy link and new causes is crucial for prevention and early detection.

Recent studies confirm genomic testing for NSCLC enhances treatment choices and survival, advocating for its standardization in clinical practice.